B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signalling to ERKs

REACTOME PATHWAY
Reactome: R-HSA-18768714 genes40 compounds

The Signalling to ERKs pathway (Reactome ID: R-HSA-187687) involves 14 genes and is affected by 40 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

BRAFGRB2MAP2K1MAP2K2MAPK1MAPK11MAPK12MAPK13MAPK14MAPK3MAPKAPK2NTRK1SRCYWHAB

Compounds Affecting Signalling to ERKs

#CompoundTargets HitStudies
1Sorafenib300
2isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
3withaferin300
4Dasatinib299
5pd980597
6trametinib296
7Afatinib297
8Quercetin300
9Anisomycin247
10tyrphostin ag 14784
11alsterpaullone12
12kenpaullone8
13sp600125117
14Axitinib298
15Vemurafenib298
16plumbagin [Supplementary Concept]300
17fisetin78
18myricetin-3-O-galactopyranoside [Supplementary Concept]300
19Crizotinib298
20Clotrimazole296
21Progesterone299
222-Chloroadenosine 2-Chloroadenosine.300
23Benzalkonium Compounds299
24Calcimycin216
25daph2
26Diphenhydramine14
27ha10044
28Lithocholic Acid300
29Loratadine296
30trequinsin hydrochloride1
31egcg300
32Celecoxib295
33Resveratrol298
34Adenosine Monophosphate Adenine nucleotide containing300
35monorden8
36Niclosamide299
37arctigenin-4-O-(3''-O-acetyl-beta-D-glucoside) [Supplementary Concept] isolated from300
38pictilisib25
39Adenosine Triphosphate300
40Dactinomycin297

About the Signalling to ERKs Pathway

The Signalling to ERKs pathway is catalogued in Reactome (ID: R-HSA-187687) and involves 14 genes. In the BiohacksAI corpus, 40 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include BRAF, GRB2, MAP2K1, MAP2K2, MAPK1.